Search
Showing results for "early lung health"
Invasive fungal disease (IFD) remains a common and serious complication in children treated for leukaemia. Antifungal prescription in children with leukaemia presents unique challenges, particularly due to variation in IFD risk between and within leukaemia treatment protocols, drug toxicities and interactions between antifungals and chemotherapeutic agents.
Wearable technologies impact upon sexual activity and this influences the decision to adopt the technology
Patients using insulin pump therapy had a better long-term glycemic control relative to the matched injection therapy cohort
This study aimed to determine the incidence and incidence rate trends of type 1 diabetes mellitus in children aged 0–14 years...
How can your organisation help improve the lives of children?
As our Key Relationships Officer, you will be responsible for developing key relationships with donors in support of the Institute’s research mission.
In 2026, Rare Disease Day is recognised on 28 February to raise awareness and generate change for people living with rare disease, their families and carers worldwide. This year’s global theme, More than you can imagine, highlights the immense impact of rare disease on families across the world.
A complex five-year experiment which cracked the code of a genetic mystery has paved the way for faster and more accurate diagnoses of the most rare and unknown diseases affecting children.
Disruptions of malaria case management caused by the COVID-19 pandemic likely contributed to an extra 76,000 malaria deaths in sub-Saharan Africa, according to analysis by The Kids Research Institute Australia and Curtin University.
Australian researchers have uncovered a new form of antimicrobial resistance (AMR) – undetectable using traditional laboratory testing methods – in a discovery set to challenge existing efforts to monitor and tackle one of the world’s greatest health threats.